Momenta Pharmaceuticals, Inc.
(NASDAQ : MNTA)

( )
MNTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.23%89.071.3%$885.86m
AMGNAmgen Inc.
0.09%191.491.2%$554.58m
GILDGilead Sciences, Inc.
0.72%65.490.9%$453.28m
ONCESpark Therapeutics, Inc.
-0.25%113.6711.2%$443.24m
BIIBBiogen Inc.
-0.58%323.761.3%$352.26m
REGNRegeneron Pharmaceuticals, Inc.
-0.15%406.992.6%$278.79m
ILMNIllumina, Inc.
1.61%310.703.5%$273.06m
BPTHBio-Path Holdings, Inc.
-9.32%25.20190.1%$257.65m
VRTXVertex Pharmaceuticals Incorporated
-3.05%181.761.9%$239.61m
SRPTSarepta Therapeutics, Inc.
-0.28%126.4715.4%$205.98m
EXASExact Sciences Corporation
-0.85%91.1525.3%$189.71m
ALXNAlexion Pharmaceuticals, Inc.
-0.43%132.942.0%$178.02m
AAgilent Technologies, Inc.
0.28%81.201.6%$151.29m
IONSIonis Pharmaceuticals, Inc.
0.11%79.618.3%$101.25m
BMRNBioMarin Pharmaceutical Inc.
-2.06%91.444.3%$95.59m

Company Profile

Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.